NHS Dudley Health Economy Medicines Formulary
Home > 10 Musculoskeletal and joint diseases > 10.1 Drugs used in rheumatic diseases and gout > 10.1.3 Drugs that suppress the rheumatic disease process > Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) - NICE TAG TA568

Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) - NICE TAG TA568

NICE is unable to make a recommendation about the use in the NHS of abatacept (Orencia) for treating psoriatic arthritis after DMARDs in adults because no evidence submission was received from Bristol–Myers Squibb. We will review this decision if the company decides to make a submission.

https://www.nice.org.uk/guidance/ta568

Site by Devopa
© Copyright 2021 NHS. All rights reserved.